The Inflation Reduction Act Will Lead To Fewer New Medicines

But, make no mistake – the IRA will have a major impact on biopharma R&D and, as a result, fewer important medicines will be available.

Source: Forbes.com Healthcare News - September 11, 2023 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma standard Source Type: news